David Deperthes

1.4k total citations
25 papers, 1.1k citations indexed

About

David Deperthes is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, David Deperthes has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 9 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in David Deperthes's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Peptidase Inhibition and Analysis (6 papers). David Deperthes is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Peptidase Inhibition and Analysis (6 papers). David Deperthes collaborates with scholars based in Canada, Switzerland and Brazil. David Deperthes's co-authors include Roland R. Tremblay, Gilles Frenette, Hans‐Jürg Leisinger, Jürg Tschopp, Nils Holler, Jürgen Engel, Pascal Schneider, Jean Dubé, Claude Lazure and Aubry Tardivel and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and European Journal of Biochemistry.

In The Last Decade

David Deperthes

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Deperthes Canada 17 517 402 234 210 199 25 1.1k
Erica N Evans United States 19 487 0.9× 288 0.7× 379 1.6× 187 0.9× 232 1.2× 44 1.2k
Lowell J. Underwood United States 12 420 0.8× 273 0.7× 212 0.9× 244 1.2× 146 0.7× 16 881
Mariana Nacht United States 17 1.0k 1.9× 235 0.6× 268 1.1× 441 2.1× 90 0.5× 27 1.5k
Y Tsujimoto United States 7 944 1.8× 199 0.5× 324 1.4× 400 1.9× 220 1.1× 8 1.5k
Roland Grenningloh United States 22 414 0.8× 332 0.8× 739 3.2× 259 1.2× 164 0.8× 39 1.4k
Sebastian Herzog Germany 21 713 1.4× 214 0.5× 485 2.1× 241 1.1× 296 1.5× 43 1.4k
A C Bloem Netherlands 18 517 1.0× 126 0.3× 532 2.3× 363 1.7× 512 2.6× 34 1.4k
Maurizio Di Liberto United States 17 1.1k 2.1× 327 0.8× 206 0.9× 494 2.4× 225 1.1× 49 1.8k
Frédéric Barabé Canada 20 732 1.4× 116 0.3× 348 1.5× 286 1.4× 416 2.1× 38 1.3k
Donatella Venturelli Italy 23 1.1k 2.0× 418 1.0× 283 1.2× 307 1.5× 638 3.2× 58 1.8k

Countries citing papers authored by David Deperthes

Since Specialization
Citations

This map shows the geographic impact of David Deperthes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Deperthes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Deperthes more than expected).

Fields of papers citing papers by David Deperthes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Deperthes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Deperthes. The network helps show where David Deperthes may publish in the future.

Co-authorship network of co-authors of David Deperthes

This figure shows the co-authorship network connecting the top 25 collaborators of David Deperthes. A scholar is included among the top collaborators of David Deperthes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Deperthes. David Deperthes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emami, Nashmil, David Deperthes, Johan Malm, & Eleftherios P. Diamandis. (2008). Major Role of Human KLK14 in Seminal Clot Liquefaction. Journal of Biological Chemistry. 283(28). 19561–19569. 36 indexed citations
2.
Kündig, Christoph, Carla A. Borgoño, Jair R. Chagas, et al.. (2006). Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14. FEBS Journal. 273(11). 2505–2514. 23 indexed citations
3.
Kishi, Tadaaki, et al.. (2006). Activation and enzymatic characterization of recombinant human kallikrein 8. Biological Chemistry. 387(6). 723–31. 29 indexed citations
4.
Kündig, Christoph, et al.. (2006). Peptabody‐EGF: A novel apoptosis inducer targeting ErbB1 receptor overexpressing cancer cells. International Journal of Cancer. 119(10). 2455–2463. 6 indexed citations
5.
Borgoño, Carla A., Christoph Kündig, Tadaaki Kishi, et al.. (2005). Enzymatic profiling of human kallikrein 14 using phage-display substrate technology. Biological Chemistry. 386(3). 291–298. 52 indexed citations
6.
Jichlinski, Patrice, et al.. (2004). Profiling of Proteolytic Activities Secreted by Cancer Cells using Phage Display Substrate Technology. Tumor Biology. 25(1-2). 24–30. 6 indexed citations
7.
Kündig, Christoph, et al.. (2004). Development of recombinant inhibitors specific to human kallikrein 2 using phage‐display selected substrates. European Journal of Biochemistry. 271(3). 607–613. 29 indexed citations
8.
Chagas, Jair R., et al.. (2002). Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology. European Journal of Biochemistry. 269(11). 2747–2754. 48 indexed citations
9.
Deperthes, David. (2002). Phage Display Substrate: A Blind Method for Determining Protease Specificity. Biological Chemistry. 383(7-8). 1107–12. 36 indexed citations
10.
Deperthes, David, et al.. (2002). Angiogenèse et cancer de vessie : marqueur tumoral à la mode ou nouvelle cible thérapeutique ?. Annales d Urologie. 36(4). 258–263. 1 indexed citations
11.
Couty, S., Alexey V. Terskikh, Martine Pugnière, et al.. (2000). Streptabody, a high avidity molecule made by tetramerization of in vivo biotinylated, phage display-selected scFv fragments on streptavidin. Molecular Immunology. 37(17). 1067–1077. 67 indexed citations
12.
Holler, Nils, Takao Kataoka, Jean-Luc Bodmer, et al.. (2000). Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors. Journal of Immunological Methods. 237(1-2). 159–173. 40 indexed citations
13.
Dubé, Jean Y., et al.. (1998). Abundant Cysteine-Rich Protein-1 is Localized in the Stromal Compartment of the Human Prostate. Archives of Andrology. 40(2). 109–115. 10 indexed citations
14.
15.
Frenette, Gilles, David Deperthes, Roland R. Tremblay, Claude Lazure, & Jean Dubé. (1997). Purification of enzymatically active kallikrein hK2 from human seminal plasma. Biochimica et Biophysica Acta (BBA) - General Subjects. 1334(1). 109–115. 56 indexed citations
16.
Deperthes, David, François Marceau, Gilles Frenette, et al.. (1997). Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1343(1). 102–106. 28 indexed citations
17.
Brillard‐Bourdet, Michéle, David Deperthes, María A. Juliano, et al.. (1997). Serpin-derived Peptide Substrates for Investigating the Substrate Specificity of Human Tissue Kallikreins hK1 and hK2. Journal of Biological Chemistry. 272(47). 29590–29595. 47 indexed citations
18.
Tremblay, Roland R., David Deperthes, Jacques Mailloux, Martin Lemay, & Jean Dubé. (1996). Kallikreins expression in a mature cystic ovarian teratoma. Journal of Clinical Laboratory Analysis. 10(4). 229–231. 9 indexed citations
19.
Deperthes, David, et al.. (1995). Identification of glandular kallikrein in dog pancreas and determination of its tissue distribution. Biochimica et Biophysica Acta (BBA) - General Subjects. 1243(3). 291–294. 3 indexed citations
20.
Deperthes, David, Pierre Chapdelaine, Roland R. Tremblay, et al.. (1995). Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochimica et Biophysica Acta (BBA) - General Subjects. 1245(3). 311–316. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erica N Evans Breakdown of academic impact, for papers by Lowell J. Underwood Breakdown of academic impact, for papers by Mariana Nacht Breakdown of academic impact, for papers by Y Tsujimoto Breakdown of academic impact, for papers by Roland Grenningloh Breakdown of academic impact, for papers by Sebastian Herzog Breakdown of academic impact, for papers by A C Bloem Breakdown of academic impact, for papers by Maurizio Di Liberto Breakdown of academic impact, for papers by Frédéric Barabé Breakdown of academic impact, for papers by Donatella Venturelli
Rankless by CCL
2026